Gosset Ownership
Private
Therapeutic Areas
Stage
Commercial
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Aspect Imaging General Information
Aspect Imaging’s MRI systems are commercially available and deployed in clinical and preclinical settings. The Embrace® Neonatal MRI System is FDA cleared and CE approved for use at the point-of-care in NICUs. No clinical trial results required as these are diagnostic devices.
Contact Information
Drug Pipeline
No pipeline data available
Key Partnerships
Yale University (installation of Embrace® system), Vizient Inc. (Innovative Technology contract)
Aspect Imaging Funding
No funding data available
To view Aspect Imaging's complete valuation and funding history, request access »